Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 87.

Naegele, M; Flammer, A J; Enseleit, F; Roas, S; Frank, M; Hirt, A; Kaiser, P; Cantatore, S; Templin, C; Fröhlich, G; Romanens, M; Lüscher, T F; Ruschitzka, F; Noll, G; Sudano, I (2016). Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. International Journal of Cardiology, 224:226-230.

Klose, G; Beil, F U; Dieplinger, H; von Eckardstein, A; Föger, B; Gouni-Berthold, I; Koenig, W; Kostner, G M; Landmesser, U; Laufs, U; Leistikow, F; März, W; Merkel, M; Müller-Wieland, D; Noll, G; Parhofer, K G; Paulweber, B; Riesen, W; Schaefer, J R; Steinhagen-Thiessen, E; Steinmetz, A; Toplak, H; Wanner, C; Windler, E (2014). Neue AHA- und ACC-Leitlinie zur Risikoreduktion von Herz-Kreislauf-Erkrankungen durch Cholesterinsenkung. Der Internist, 55(5):601-606.

Sudano, I; Pourmand, A; Schoenenberger-Berzins, R; Suter, P M; Roas, S; Templin, C; Landmesser, U; Noll, G; Battegay, E; Erne, P; Lüscher, T F (2014). Klinische Effekte der katheterbasierten Nierennervenablation bei therapieresistenter Hypertonie. Cardiovascular Medicine, 17(1):8-13.

Klose, G; Beil, F U; Dieplinger, H; von Eckardstein, A; Foger, B; Gouni-Berthold, I; Heigl, F; Koenig, W; Kostner, G M; Landmesser, U; Laufs, U; Leistikow, F; Marz, W; Noll, G; Parhofer, K G; Paulweber, B; Riesen, W F; Schaefer, J R; Steinhagen-Thiessen, E; Steinmetz, A; Toplak, H; Wanner, C; Windler, E (2014). New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Wiener Klinische Wochenschrift, 126(5-6):169-175.

Wuerzner, G; Muller, O; Erne, P; Cook, S; Sudano, I; Luscher, T F; Noll, G; Kaufmann, U; Rickli, H; Waeber, B; Kaiser, C; Sticherling, C; Pechere-Bertschi, A; Baumgartner, I; Jacob, A L; Burnier, M; Qanadli, S D (2014). Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus. Swiss Medical Weekly, 144:w13913.

Raess, M; Frohlich, G; Roos, Malgorzata; Rusi, B; Wilhelm, M J; Noll, G; Ruschitzka, F; Fehr, T; Enseleit, F (2013). Donor-specific anti-HLA antibodies detected by Luminex: predictive for short-term but not long-term survival after heart transplantation. Transplant International, 26(11):1097-1107.

Frohlich, G M; Keller, P; Schmid, F; Wolfrum, M; Osranek, M; Falk, C; Noll, G; Enseleit, F; Reinthaler, M; Meier, P; Luscher, T F; Ruschitzka, F; Tanner, F C (2013). Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. European Heart Journal, 34(19):1414-1423.

Schafer, H H; de Villiers, J D; Lotze, U; Sivukhina, E; Burnier, M; Noll, G; Theus, G R; Dieterle, T (2013). Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in swiss primary care. Clinical and Experimental Hypertension, 35(7):496-505.

Sudano, I; Noll, G; Luscher, T F (2013). Potential new indications and future studies. EuroIntervention, 9 Suppl :R155-R160.

Wenger, U; Cottini, S R; Noll, G; Arndt, S; Stehberger, P A; Klinzing, S; Schuepbach, R A; Bechir, M (2013). Pretransplant dyslipidaemia determines outcome in lung transplant recipients. Lipids in Health and Disease, 12:53.

Templin, C; Jaguszewski, M; Ghadri, J R; Sudano, I; Gaehwiler, R; Hellermann, J P; Schoenenberger-Berzins, R; Landmesser, U; Erne, P; Noll, G; Luscher, T F (2013). Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity(R) catheter system and the EnligHTN multi-electrode renal denervation catheter. European Heart Journal, 34(28):2141-2148.

Schafer, H H; Sudano, I; Theus, G R; Zilla, P; Noll, G; Burnier, M (2012). Blood pressure target attainment in the background of guidelines: the very elderly in Swiss primary care. Family Practice, 29(5):511-520.

Flammer, A J; Sudano, I; Wolfrum, M; Thomas, R; Enseleit, F; Périat, D; Kaiser, P; Hirt, A; Hermann, M; Serafini, M; Lévêques, A; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2012). Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. European Heart Journal, 33(17):2172-2180.

Sudano, I; Flammer, A J; Roas, S; Enseleit, F; Ruschitzka, F; Corti, R; Noll, G (2012). Cocoa, blood pressure, and vascular function. Current Hypertension Reports, 14(4):279-284.

Sudano, I; Roas, S; Flammer, A J; Noll, G; Ruschitzka, F (2012). Effekt von Paracetamol auf den Blutdruck bei Patienten mit koronarer Herzkrankheit. Praxis, 101(12):775-779.

Luscher, T F; Landmesser, U; Wolfrum, M; Noll, G; Sudano, I (2012). Interventional treatment of essential hypertension: renal sympathetic denervation. In: Eeckout, E; Serruys, P W; Wijns, W; Vahanian, A; van Sambeek, M R H M; De Palma, R. Percutaneous Interventional Cardiovascular Medicine: The PCR-EAPCI Textbook. Toulouse: Europa Edition, online.

Schäfer, H H; de Villiers, J D; Sudano, I; Theus, G R; Sivukhina, E; Burnier, M; Dieterle, T; Noll, G (2012). Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care. International Journal of Clinical Practice, 66(11):1125-1126.

Sudano, I; Flammer, A J; Roas, S; Enseleit, F; Noll, G; Ruschitzka, F (2012). Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension. Current Hypertension Reports, 14(4):304-309.

Hermann, M; Enseleit, F; Fisler, A E; Flammer, A; Lüscher, T F; Noll, G; Ruschitzka, F (2011). Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation. Swiss Medical Weekly, 141:w13149.

Frey, S; Prêtre, René; Stiasny, B; Noll, G; Ruschitzka, F; Balmer, C (2011). Morbidity and mortality in children and adolescents listed for heart transplantation. Cardiovascular Medicine, 14(6):176-181.

Toggweiler, S; Borst, O; Enseleit, F; Hermann, M; Ruschitzka, F; Lüscher, T F; Noll, G (2011). NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings. Clinical Cardiology, 34(3):183-188.

Sudano, I; Hess, L; Noll, G; Arnet, D (2011). Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patients. Swiss Medical Weekly, 141:w13200.

Sudano, I; Roas, S; Noll, G (2011). Vascular abnormalities in essential hypertension. Current Pharmaceutical Design, 17(28):3039-3044.

Hürlimann, D; Steffel, J; Krasniqi, N; Milosevic, G; Gruner, C; Oswald, F; Rahn, M; Falk, V; Noll, G; Lüscher, T F; Ruschitzka, F; Holzmeister, J (2010). Kardiale Resynchronisationstherapie: "Real World"-Erfahrungen eines tertiären Zentrum in der Schweiz. Cardiovascular Medicine, 13(11):334-341.

Sudano, I; Flammer, A J; Périat, D; Enseleit, F; Hermann, M; Wolfrum, M; Hirt, A; Kaiser, P; Hurlimann, D; Neidhart, M; Gay, S; Holzmeister, J; Nussberger, J; Mocharla, P; Landmesser, U; Haile, S R; Corti, R; Vanhoutte, P M; Lüscher, T F; Noll, G; Ruschitzka, F (2010). Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation, 122(18):1789-1796.

Corti, R; Perdrix, J; Flammer, A J; Noll, G (2010). Chocolat noir ou chocolat blanc? Le cacao et la santé cardiovasculaire. Revue Médicale Suisse, 6(239):499-502.

Enseleit, F; Ruschitzka, F; Noll, G (2010). Diagnostik und medikamentöse Therapie der Herzinsuffizienz: Der Hausarzt stellt wichtige Weichen. Hausarzt Praxis, 5:7-9.

Morf, S; Hochuli, M; Elke, B; Noll, G (2010). Herzinsuffizienz Teil 2: Therapie. Praxis, 99(2):83-93.

Romanens, M; Ackermann, F; Spence, J; Darioli, R; Rodondi, N; Corti, R; Noll, G; Schwenkglenks, M; Pencina, M (2010). Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics. European Journal of Cardiovascular Prevention and Rehabilitation, 17(1):18-23.

Binggeli, C; Sudano, I; Corti, R; Spieker, L; Jenni, R; Lüscher, T F; Noll, G (2010). Spontanous periodic breathing is associated with sympathetic hyperreactivity and baroreceptor dysfunction in hypertension. Journal of Hypertension, 28(5):985-992.

Goetzmann, L; Lieberherr, M; Krombholz, L; Ambühl, P; Boehler, A; Noll, G; Muellhaupt, B; Wagner, R; Buddeberg, C; Klaghofer, R (2010). Subjektives Erleben nach einer Organtransplantation – eine qualitative Studie mit 120 Herz-, Lungen-, Leber und Nierenempfängern. Zeitschrift für Psychosomatische Medizin und Psychotherapie, 56(3):268-282.

Morf, S; Hochuli, M; Elke, B; Noll, G (2009). Herzinsuffizienz Teil 1: Klinik, Ursachen, Abklärungsstrategie. Praxis, 98(25):1483-1492.

Romanens, M; Corti, R; Noll, G; Zellweger, M (2009). Screening tools for coronary artery disease (CAD) in asymptomatic subjects: the role of stress testing. A contribution of the tsk Force on Vascular Risk Prediction. Kardiovaskuläre Medizin, 12(12):327-332.

Greutmann, M; Prêtre, René; Furrer, L; Bauersfeld, U; Turina, M; Noll, G; Luescher, T F; Trindade, P T (2009). Heart transplantation in adolescent and adult patients with congenital heart disease: a case-control study. Transplantation Proceedings, 41(9):3821-3826.

Tebbe, U; Bramlage, P; Thoenes, M; Paar, W D; Danchin, N; Volpe, M; Schrader, J; Noll, G; Burnier, M; Böhm, M (2009). Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Medical Weekly, 139(33-34):473-480.

Sudano, I; Noll, G (2009). Dual blockade versus single blockade of the renin-angiotensin system in the light of ONTARGET. Journal of Hypertension, 27(Suppl. 6):S11-S14.

Flammer, A J; Vo, N T T; Ledergerber, B; Hermann, F; Gämperli, A; Huttner, A; Evison, J; Baumgartner, I; Cavassini, M; Hayoz, D; Quitzau, K; Hersberger, M; Sudano, I; Ruschitzka, F; Lüscher, T F; Noll, G; Weber, R (2009). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomized controlled trial. Heart, 95(5):385-390.

Camici, G G; Sudano, I; Noll, G; Tanner, F C; Lüscher, T F (2009). Molecular pathways of aging and hypertension. Current Opinion in Nephrology and Hypertension, 18(2):134-137.

Hermann, F; Enseleit, F; Spieker, L; Periat, D; Sudano, I; Hermann, M; Corti, R; Noll, G; Ruschitzka, F; Luscher, T F (2009). Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia. Thrombosis Research, 123(3):460-465.

Darioli, R; Meier, B; Noll, G (2009). Aufruf zur Verbesserung des Cholesterin-managements. Kardiovaskuläre Medizin, 12(5):151-159.

Kovacevic-Preradovic, T; Jenni, R; Oechslin, E N; Noll, G; Seifert, Burkhardt; Attenhofer Jost, C H (2009). Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience. Cardiology, 112(2):158-164.

Goetzmann, L; Ruegg, L; Stamm, M; Ambühl, P; Boehler, A; Halter, J; Muellhaupt, B; Noll, G; Schanz, U; Wagner-Huber, R; Spindler, A; Buddeberg, C; Klaghofer, R (2008). Psychosocial profiles after transplantation: a 24-month follow-up of heart, lung, liver, kidney and allogeneic bone-marrow patients. Transplantation, 86(5):662-668.

Sudano, I; Flammer, A J; Hermann, F; Syburra, T; Kaiser, P; Hirt, A; Hermann, M; Corti, R; Ruschitzka, F; Zund, G; Noll, G (2008). Auricall: A new device for a non-invasive, wireless, continuous monitoring of oxygen saturation and heart rate in patients with heart failure. International Journal of Cardiology, 129(1):141-143.

Goetzmann, L; Sarac, N; Ambühl, P; Boehler, A; Irani, S; Muellhaupt, B; Noll, G; Schleuniger, M; Schwegler, K; Buddeberg, C; Klaghofer, R (2008). Psychological response and quality of life after transplantation: a comparison between heart, lung, liver and kidney recipients. Swiss Medical Weekly, 138(33-34):477-483.

Sudano, I; Périat, D; Noll, G (2008). Das Endocannabinoid-System. Praxis, 97(7):375-380.

Flammer, A J; Sudano, I; Hermann, F; Gay, S; Forster, A; Neidhart, M; Künzler, P; Enseleit, F; Périat, D; Hermann, M; Nussberger, J; Luscher, T F; Corti, R; Noll, G; Ruschitzka, F (2008). Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation, 117(17):2262-2269.

Periat, D; Sudano, I; Enseleit, F; Noll, G (2008). Betablocker. In: Enseleit, F; Ruschitzka, F. Koronare Herzerkrankung und Herzinfarkt - Aktuelle Studien zur Sekündärprävention( KHK und Herzinfarkt - Aktuelle Studien zur Sekundärprävention). Bremen: UNI-MED Verlag, 82-88.

Cosentino, F; Hürlimann, D; Delli Gatti, C; Chenevard, R; Blau, N; Alp, N J; Channon, K M; Eto, M; Lerch, P; Enseleit, F; Ruschitzka, F; Volpe, M; Lüscher, T F; Noll, G (2008). Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart, 94(4):487-492.

Klaghofer, R; Sarac, N; Schwegler, K; Schleuniger, M; Noll, G; Muellhaupt, B; Ambuehl, P; Boehler, A; Irani, S; Buddeberg, C; Goetzmann, L (2008). Fragebogen zur psychischen Verarbeitung einer Organtransplantation: Deutsche Validierung des Transplant Effects Questionnaire (TxEQ). Zeitschrift für Psychosomatische Medizin und Psychotherapie, 54(2):174-188.

Riesen, W F; Noll, G; Dariolo, R (2008). Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia. Swiss Medical Weekly, 138(29-30):420-426.

Flammer, A J; Sudano, I; Noll, G; Corti, R (2008). Kakao: eine Leseprobe. Praxis, 97(8):443-446.

Enseleit, F; Mueller, N J; Duru, F; Lachat, M; Noll, G; Ruschitzka, F (2008). Teicoplanin-induced complete AV-block in a heart transplant recipient. Infection, 36(3):291-292.

Kohler, M; Amann-Vesti, B R; Clarenbach, C F; Brack, T; Noll, G; Russi, E W; Bloch, K E (2007). Periodic whole body acceleration: a novel therapy for cardiovascular disease. VASA, 36(4):261-266.

Béchir, M; Schwegler, K; Chenevard, R; Binggeli, C; Caduff, C; Büchi, S; Buddeberg, C; Lüscher, T F; Noll, G (2007). Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders. Autonomic Neuroscience, 134(1-2):69-73.

Sudano, I; Virdis, A; Taddei, S; Spieker, I; Corti, R; Noll, G; Salvetti, A; Lüscher, T F (2007). Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. Hypertension, 49(2):285-290.

Flammer, A J; Hermann, F; Sudano, I; Spieker, L; et al; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2007). Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation, 116(21):2376-2382.

Brack, T; Thüer, I; Clarenbach, C F; Senn, O; Noll, G; Russi, E W; Bloch, K E (2007). Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest, 132(5):1463-1471.

Flammer, A J; Hermann, F; Wiesli, P; Schwegler, B; Chenevard, R; Hurlimann, D; Sudano, I; Gay, S; Neidhart, M; Riesen, W; Ruschitzka, F; Lüscher, T F; Noll, G; Lehmann, R (2007). Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. Journal of Hypertension, 25(4):785-791.

Spieker, L E; Flammer, A J; Amacker, N; Sudano, I; Badimon, J J; Ruschitzka, F; Luscher, T F; Noll, G; Corti, R (2006). C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis. Thrombosis and Haemostasis, 96(4):540-542.

Sudano, I; Spieker, L E; Noll, G; Corti, R; Weber, R; Lüscher, T F (2006). Cardiovascular disease in HIV infection. American Heart Journal, 151(6):1147-1155.

Hermann, F; Spieker, L E; Ruschitzka, F; Sudano, I; Hermann, M; Binggeli, C; Lüscher, T F; Riesen, W; Noll, G; Corti, R (2006). Dark chocolate improves endothelial and platelet function. Heart, 92(1):119-120.

Sudano, I; Flammer, A; Noll, G; Luscher, T F (2006). Der hohe Blutdruck. Herz, 31(1):81-82.

Hurlimann, D; et al; Béchir, M; Noll, G (2006). Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial. Heart, 92(1):110-112.

Enseleit, F; Wyss, C A; Duru, F; Noll, G; Ruschitzka, F (2006). Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration. Circulation, 113(5):e63.

Chenevard, R; Béchir, M; Hürlimann, D; Ruschitzka, F; Turina, J; Lüscher, T F; Noll, G (2006). Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery. Heart, 92(12):1862-1863.

Sudano, I; Spieker, L E; Hermann, F; Flammer, A; Corti, R; Noll, G; Luscher, T F (2006). Protection of endothelial function: targets for nutritional and pharmacological interventions. Journal of Cardiovascular Pharmacology, 47 Sup:S136-S150.

Sudano, I; et al; Ruschitzka, F; Noll, G (2005). Cardiovascular effects of coffee: is it a risk factor? Progress in Cardiovascular Nursing, 20(2):65-69.

Sudano, I; Spieker, L; Binggeli, C; Ruschitzka, F; Lüscher, T F; Noll, G; Corti, R (2005). Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers. Hypertension, 46(3):521-526.

Hermann, F; Ruschitzka, F; Spieker, L; Sudano, I; Noll, G; Corti, R (2005). Das süße Geheimnis der dunklen Schokolade. Therapeutische Umschau, 62(9):635-637.

Béchir, M; Enseleit, F; Chenevard, R; Lüscher, T F; Noll, G (2005). Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension. American Journal of Cardiology, 95(1):129-131.

Noll, G; et al; Lüscher, T F (2005). Endogenous estrogens increase postischemic hyperemia in the skin microcirculation. Journal of Cardiovascular Pharmacology, 45(5):414-417.

Bechir, M; Enseleit, F; Chenevard, R; Muntwyler, J; Lüscher, T F; Noll, G (2005). Folic Acid improves baroreceptor sensitivity in hypertension. Journal of Cardiovascular Pharmacology, 45(1):44-48.

Corti, R; Sudano, I; Spieker, L; Binggeli, C; Hermann, F; Toenz, D; Noll, G (2005). Kaffee - Gift oder Medizin? Therapeutische Umschau, 62(9):629-633.

Hermann, F; et al; Noll, G; Ruschitzka, F (2005). Simvastatin improves endothelial function in patients with rheumatoid arthritis. Journal of the American College of Cardiology, 45(3):461-464.

Spieker, L E; Ruschitzka, F; Lüscher, T F; Noll, G (2004). HDL and inflammation in atherosclerosis. Current Drug Targets. Immune, Endocrine & Metabolic Disorders, 4(1):51-57.

Riesen, W F; Darioli, R; Noll, G (2004). Lipid-lowering therapy: strategies for improving compliance. Current Medical Research and Opinion, 20(2):165-173.

Karadag, B; Spieker, L E; Schwitter, J; Ruschitzka, F; Lüscher, T F; Noll, G; Corti, R (2004). Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging. Cardiology in Review, 12(4):185-187.

Spieker, L E; Ruschitzka, F; Badimon, J J; Noll, G; Corti, R (2004). Shear stress-dependent platelet function after LDL cholesterol apheresis. Thrombosis Research, 113(6):395-398.

Ruschitzka, F; et al; Noll, G; Lüscher, T F; Hänseler, E (2003). Detection of a novel exon 4 low-density lipoprotein receptor gene deletion in a swiss family with severe familial hypercholesterolemia. Clinical Chemistry and Laboratory Medicine, 41(3):266-271.

Béchir, M; Binggeli, C; Corti, R; Chenevard, R; Spieker, L; Ruschitzka, F; Lüscher, T F; Noll, G (2003). Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation, 107(12):1620-1625.

Spieker, L E; Lüscher, T F; Noll, G (2003). ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humans. Journal of Cardiovascular Pharmacology, 42(3):315-318.

Andreas, S; Bingeli, C; Mohacsi, P; Luscher, T F; Noll, G (2003). Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest, 123(2):366-371.

Spieker, L; Noll, G (2003). Pathophysiologische Herz-Kreislauf-Veränderungen bei Stress und Depression. Therapeutische Umschau, 60(11):667-672.

Chenevard, R; et al; Lüscher, T F; Noll, G; Ruschitzka, F (2003). Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation, 107(3):405-409.

Binggeli, C; Spieker, L E; Corti, R; Sudano, I; Stojanovic, V; Hayoz, D; Lüscher, T F; Noll, G (2003). Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? Journal of the American College of Cardiology, 42(1):71-77.

Vorschläge einer interdisziplinären Arbeitsgruppe zur Diagnostik und Therapie des metabolischen Syndroms. Edited by: Lehmann, Roger; Gutzwiller, Felix; Battegay, Edouard; Burnier, M; Carrel, J; Diem, P; Gaillard, R; Greminger, P; Lareida, J; Muggli, F; Noll, G; Philipp, J; Riesen, Walter F; Spinas, G A (2003). Basel: EMH.

Ruschitzka, F T; Wenger, R H; Stallmach, T; Quaschning, T; de Wit, C; Wagner, K; Labugger, R; Kelm, M; Noll, G; Rülicke, T; Shaw, S; Lindberg, R L; Rodenwaldt, B; Lutz, H; Bauer, C; Lüscher, T F; Gassmann, M (2000). Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 97(21):11609-11613.

This list was generated on Mon Sep 25 13:00:30 2017 CEST.